Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Cal Gary who wrote (8402)	1/10/2002 9:48:29 AM
From: Cal Gary	Respond to of 14101

OT Daja Vu III Look at HML go! $9.35 on expectation of HC approval. Sounds familar? Their investor did the calendar thing. Its now past due in Dec and now its a New Year date for approval. Sounds familar? Some differences between DMX and HML: 1. their phase III for USA is just getting underway. I believe they are still waiting for another stamp. 2. their stock price is showing the premium 3. they are seeking MCA, while we got it and selling into 1 of 5 EU countries 4. DMX is at the door with FDA for Pennsaid 5. ... In a way I envy them, while in the same breathe, feel sad for them while they figure out the HC dance without FDA. PS I hope DMX CFO knocks on VenGrowth's doors. <g>